Get started
Author

Sara Goldberger

Observed names: Goldberger, Sara, Sara Goldberger (3477710)
OpenAlex ID: A5005966487
Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey
2016 · Ruben Mesa, Carole B. Miller, et al. · BMC Cancer · 197
PDF
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey
2016 · Ruben A. Mesa, Carole B. Miller, et al. · Cancer · 89
PDF
A pilot feasibility study of a group-delivered cancer parenting program: Enhancing Connections-Group
2020 · Frances Marcus Lewis, Ellen H. Zahlis, et al. · Journal of Psychosocial Oncology · 18
Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Overall Health and Productivity: Results from the MPN LANDMARK SURVEY in the United States
2014 · Ruben Mesa, Carole B Miller, et al. · Blood · 14
CancerSupportSource®-15+: development and evaluation of a short form of a distress screening program for cancer patients and survivors
2021 · Alexandra K. Zaleta, Shauna McManus, et al. · Supportive Care in Cancer · 8
PDF
Hydroxyurea Treatment History and Quality of Life in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United States
2015 · Ruben A. Mesa, Carole B. Miller, et al. · Blood · 6
Phlebotomy Frequency and Quality of Life and Productivity in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United States
2015 · Salman Fazal, Carole B. Miller, et al. · Blood · 5
Financial Burden of Myeloproliferative Neoplasms on Patients: Results from the MPN Landmark Survey in the United States
2015 · Shreekant V. Parasuraman, Ahmad B. Naim, et al. · Blood · 3
Gaps in Perception Between Patients and Physicians Regarding Symptomatology and Treatment Attitudes for Myeloproliferative Neoplasms: MPN LANDMARK SURVEY
2014 · Ruben Mesa, Carole B Miller, et al. · Blood · 2
Valued Outcomes in the Cancer Experience (VOICE)™: Development and validation of a multidimensional measure of perceived control
2022 · Alexandra K. Zaleta, Erica E. Fortune, et al. · Palliative & Supportive Care · 1
PDF
HSR19-100: CancerSupportSource®-15: Development and Evaluation of a Short Form of a Distress Screening Program for Cancer Survivors
2019 · Shauna McManus, Alexandra K. Zaleta, et al. · Journal of the National Comprehensive Cancer Network · 1
HSR19-113: Valued Outcomes in the Cancer Experience (VOICE™): Scale Development and Initial Validation
2019 · Alexandra K. Zaleta, Shauna McManus, et al. · Journal of the National Comprehensive Cancer Network · 1
Valued outcomes in the cancer experience: Patient priorities and control.
2018 · Alexandra Katherine Zaleta, Shauna McManus, et al. · Journal of Clinical Oncology · 1
Impact of a Patient-Access Program with Integrated Distress Screening on Resource Utilization and Psychosocial Distress Levels in Patients with Multiple Myeloma
2014 · Victoria Kennedy, Joanne S. Buzaglo, et al. · Blood · 1
MPN-407 Talking about Blood Counts, Treatment Goals, and Health Equity in Myelofibrosis Treatment: Findings from a Patient Advocacy Group Consensus Panel
2024 · David Dubinski, Ann Brazeau, et al. · Clinical Lymphoma Myeloma & Leukemia
Talking About Blood Counts, Treatment Goals, and Health Equity in Myelofibrosis Treatment: Findings From a Patient Advocacy Group Consensus Panel
2024 · David Dubinski, Ann Brazeau, et al. · Clinical Lymphoma Myeloma & Leukemia
HSR21-076: Valued Outcomes in the Cancer Experience (VOICE™): Developing and Validating a Measure of Patient Experience
2021 · Alexandra K. Zaleta, Erica E. Fortune, et al. · Journal of the National Comprehensive Cancer Network
Additional file 1: Table S1. of Myeloproliferative neoplasms (MPNs) have a significant impact on patientsâ overall health and productivity: the MPN Landmark survey
2016 · Mesa, Ruben, Miller, Carole, et al. · Figshare
PDF
Works count: 20
Citation count: 347
H-index: 6
I10-index: 4
Year
Topic
Type